Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Autoimmune Disorders01:29

Autoimmune Disorders

1.4K
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
1.4K
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

2.7K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.7K
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

1.8K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.8K
Transcytosis of IgG01:15

Transcytosis of IgG

4.0K
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
4.0K
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

449
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
449
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

422
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
422

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MIG in Cutaneous Systemic Lupus Erythematosus.

La Clinica terapeutica·2019
Same author

Contact dermatitis and interferon-γ dependent chemokines.

La Clinica terapeutica·2016
Same author

Sjögren's syndrome and chemokines.

La Clinica terapeutica·2014
Same author

[CXCR3 and CXCL10 in autoimmune thyroiditis].

La Clinica terapeutica·2014
Same author

IP-10 in autoimmune thyroiditis.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2014
Same author

Hepatitis C virus infection and type 2 diabetes.

La Clinica terapeutica·2013

Related Experiment Video

Updated: Jan 4, 2026

Author Spotlight: A Focus on Standardized Salivary Gland Ultrasound Protocol in Connective Tissue Disease Research
07:25

Author Spotlight: A Focus on Standardized Salivary Gland Ultrasound Protocol in Connective Tissue Disease Research

Published on: October 13, 2023

4.8K

Sjögren syndrome and MIG.

I Ruffilli1

  • 1Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

La Clinica Terapeutica
|November 8, 2019
PubMed
Summary

Monokine induced by interferon-gamma (MIG) is upregulated in Sjögren syndrome (SS), recruiting T-helper 1 lymphocytes and perpetuating autoimmune responses. Targeting MIG may offer a therapeutic strategy for SS patients.

Area of Science:

  • Immunology
  • Rheumatology
  • Cell Biology

Background:

  • Sjögren syndrome (SS) is a chronic autoimmune disease targeting exocrine glands.
  • Increased expression of monokine induced by interferon-gamma (MIG) and its receptor CXCR3 is observed in SS salivary glands.
  • MIG is implicated in the pathogenesis of SS, particularly in the recruitment of immune cells.

Purpose of the Study:

  • To investigate the role of MIG in Sjögren syndrome pathogenesis.
  • To explore the mechanism of MIG-mediated immune cell recruitment in SS.
  • To evaluate the potential of MIG antagonists as a therapeutic approach for SS.

Main Methods:

  • Analysis of MIG and CXCR3 expression in salivary glands of SS patients.
  • In vitro studies using cultured SS salivary epithelial cells treated with interferon-gamma (IFN-γ).
Keywords:
MIGSjögren syndrome

More Related Videos

Author Spotlight: Oral Candida Diagnosis to Advance Clinical Treatment Regimen for pSS Patients
05:26

Author Spotlight: Oral Candida Diagnosis to Advance Clinical Treatment Regimen for pSS Patients

Published on: March 1, 2024

1.8K
Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

699

Related Experiment Videos

Last Updated: Jan 4, 2026

Author Spotlight: A Focus on Standardized Salivary Gland Ultrasound Protocol in Connective Tissue Disease Research
07:25

Author Spotlight: A Focus on Standardized Salivary Gland Ultrasound Protocol in Connective Tissue Disease Research

Published on: October 13, 2023

4.8K
Author Spotlight: Oral Candida Diagnosis to Advance Clinical Treatment Regimen for pSS Patients
05:26

Author Spotlight: Oral Candida Diagnosis to Advance Clinical Treatment Regimen for pSS Patients

Published on: March 1, 2024

1.8K
Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

699
  • Measurement of MIG and IFN-γ-inducible protein 10 (IP-10) release.
  • Assessment of T-helper 1 (Th1) lymphocyte recruitment.
  • Evaluation of MIG antagonists in experimental models of autoimmune sialadenitis.

    • Main Results:

    • Elevated expression of MIG and CXCR3 in ductal epithelium and lymphocytes of SS salivary glands.
    • IFN-γ stimulation of SS salivary epithelial cells leads to increased release of IP-10 and MIG.
    • Secreted MIG recruits Th1 lymphocytes, creating a feedback loop that enhances IFN-γ induction and perpetuates autoimmunity.
    • High MIG levels in saliva and tears suggest a Th1-dependent immune response.
    • MIG antagonists demonstrated amelioration of autoimmune sialadenitis in experimental settings.

    Conclusions:

    • MIG plays a significant role in SS pathogenesis by recruiting Th1 lymphocytes and amplifying the autoimmune process.
    • The MIG-mediated feedback loop involving IFN-γ is a key mechanism in SS.
    • MIG antagonists show promise as a potential therapeutic strategy for SS.
    • Further research is warranted to confirm MIG as a therapeutic target in human SS.